Full Text View
Tabular View
No Study Results Posted
Related Studies
Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome (MATOCSS)
This study is ongoing, but not recruiting participants.
Study NCT00527566.   Last updated on April 16, 2009.
Information provided by Brigham and Women's Hospital
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Churg Strauss Syndrome
Additional conditions recognized in this trial
Churg-Strauss Syndrome
Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Disease
Granuloma
Lymphatic Diseases
Lymphoproliferative Disorders
Pathologic Processes
Vascular Diseases
Vasculitis
Interventions listed in this trial
Mepolizumab
Sponsors listed in this trial
Brigham and Women's Hospital
GlaxoSmithKline


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services